DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Jubilant Pharmova Limited — Outcome of Board Meeting

NSE 2 hrs ago·10 Aug 2026, 1:46 pm

Jubilant Pharmova

Jubilant Pharmova Limited has informed the stock exchange regarding its financial results for the period ending June 30, 2026. The company has submitted these updates to ensure transparency and compliance with market regulations.

For investors, this announcement signals that the company is finalizing its quarterly performance data. While the specific figures are not yet disclosed, the submission marks a key step in the reporting cycle, allowing stakeholders to track the company's operational progress and financial health.

Investors should look out for the detailed financial results release. Key areas of focus will include revenue growth, profit margins, and any commentary on future business outlooks, which will provide a clearer picture of the company's trajectory.